Welcome to the Andreasson Lab
We are interested in understanding the mechanisms by which neuroinflammation elicits synaptic and neuronal injury in chronic and acute models of neurological disease.
Our foot in the door has been the study of the cyclooxygenase-2 (COX-2) pathway and its downstream prostaglandin receptor signaling pathways, which function in important ways in modulating the inflammatory response in brain in models of:
Models of Neurological Disease
- Alzheimer's Disease (AD)
- Amyotrophic Lateral Sclerosis (ALS)
- Parkinson's Disease (PD)
- Cerebrovascular Disease (stroke)
Thus this pathway functions across a broad spectrum of neurodegenerative diseases, and may potentially modulate inflammatory responses and neuronal injury via conserved cellular and molecular mechanisms.
We use genetic and pharmacologic strategies as well as in vitro culture approaches to define COX-2/prostaglandin receptor mediated mechanisms of action in eliciting synaptic and neuronal injury in models of human neurological disease.
Our Long Term Goals
- Further understand how neuroinflammatory processes injure synapses and neurons and disrupt circuits.
- Define the contribution of the COX-2/prostaglandin signaling pathways in this process.
- Develop therapeutic strategies targeting injurious inflammatory processes in human neurological diseases.
Neurology & Neurological Sciences
The Andreasson Lab is part of the Department of Neurology & Neurological Sciences.
Resources
Contact Us
Jackie Bautista
Administrative Associate
Office (650) 498-5855
Fax (650) 498-6262
jackieb@stanford.edu